Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 5/20 | 0.75 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.75 |
| ▸ | MEN1 | O00255 | 2/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.75 |
| ▸ | PI4KA | P42356 | 2/20 | 0.75 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.75 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.75 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.75 |
| ▸ | DPP4 | P27487 | 1/20 | 0.75 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.75 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.75 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.75 |
| ▸ | GAPDH | P04406 | 1/20 | 0.75 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.75 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.75 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.75 |
| ▸ | STAT6 | P42226 | 1/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.75 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.75 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29388656 | 1.00 | ADORA3 (0.75) | ADORA3ADORA1MEN1KMT2API4KA | |
| SCHEMBL12746919 | 1.00 | ADORA3 (0.75) | ADORA3ADORA1MEN1KMT2API4KA | |
| SCHEMBL29941460 | 1.00 | ADORA3 (0.75) | ADORA3ADORA1MEN1KMT2API4KA | |
| SCHEMBL23050294 | 1.00 | ADORA3 (0.75) | ADORA3ADORA1MEN1KMT2API4KA | |
| SCHEMBL12031327 | 1.00 | ADORA3 (0.75) | ADORA3ADORA1MEN1KMT2API4KA | |
| SCHEMBL24538798 | 1.00 | ADORA3 (0.75) | ADORA3ADORA1MEN1KMT2API4KA | |
| SCHEMBL2550330 | 1.00 | ADORA3 (0.75) | ADORA3ADORA1MEN1KMT2API4KA | |
| SCHEMBL12150808 | 1.00 | ADORA3 (0.75) | ADORA3ADORA1MEN1KMT2API4KA | |
| SCHEMBL25937 | 1.00 | ADORA3 (0.75) | ADORA3ADORA1MEN1KMT2API4KA | |
| SCHEMBL16359957 | 1.00 | ADORA3 (0.75) | ADORA3ADORA1MEN1KMT2API4KA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4641 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139251-A1 | RNAi Agents for Inhibiting Expression of Mucin 5AC (MUC5AC), Compositions Thereof, and Methods of Use | ARROWHEAD PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | claimed |
| WO-2026102302-A1 | POLYNUCLEOTIDES CONTAINING A MODIFIED 3'-REGION | MODERNATX, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| US-20260132406-A1 | RNAi Agents for Inhibiting Expression of Activin Receptor-Like Kinase 7 (ALK7), Compositions Thereof, and Methods of Use | ARROWHEAD PHARMACEUTICALS INC (US) | 2026-05-14 | — | — | US | claimed |
| EP-4739343-A2 | CIRCULAR RNA VACCINES FOR SEASONAL FLU AND METHODS OF USES | Shanghai Circode Biomed Co., Ltd (CN) | 2026-05-13 | — | — | EP | claimed |
| EP-4731229-A1 | SIRNA, CONJUGATE WHICH CONTAIN SIRNA, PHARMACEUTICAL COMPOSITION AND USES THEREOF | Hansoh Bio LLC (US) | 2026-04-29 | — | — | EP | claimed |
| US-20260092276-A1 | Carbohydrate-oligonucleotide conjugates, pharmaceutical compositions, and therapeutic applications | KYLONOVA XIAMEN BIOPHARMA CO LTD (CN) | 2026-04-02 | — | — | US | claimed |
| US-12582668-B2 | Methods for the treatment of alpha-1 antitrypsin deficiency (AATD) | Arrowhead Pharmaceuticals, Inc. (US) | 2026-03-24 | — | — | US | claimed |
| US-20260078375-A1 | RNAi Agents for Inhibiting Influenza A Viral Gene Expression, Compositions Thereof, and Methods of Use | ARROWHEAD PHARMACEUTICALS INC (US) | 2026-03-19 | — | — | US | claimed |
| EP-4705481-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | Orna Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4705468-A1 | MAMMALIAN POLYCISTRONIC EXPRESSION SYSTEM FOR DIRECT TRANSLATION FROM RNA AND SECRETION OF CARGO | California Institute of Technology (US) | 2026-03-11 | — | — | EP | claimed |
| EP-1313752-A2 | METHODS FOR SYNTHESIZING NUCLEOSIDES, NUCLEOSIDE DERIVATIVES AND NON-NUCLEOSIDE DERIVATIVES | RIBOZYME PHARMACEUTICALS, INC. (US) | 2003-05-28 | — | — | EP | claimed |
| US-20030007961-A1 | Orthomolecular vitamin E derivatives | WILBURN MICHAEL D (US) | 2003-01-09 | — | — | US | claimed |
| US-20020120129-A1 | Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives | RIBOZYME PHARMACEUTICALS, INC. | 2002-08-29 | — | — | US | claimed |
| WO-2002057425-A2 | NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RNA-DEPENDENT RNA VIRAL POLYMERASE | MERCK & CO., INC. (US) | 2002-07-25 | — | — | WO | claimed |
| WO-2002018405-A2 | METHODS FOR SYNTHESIZING NUCLEOSIDES, NUCLEOSIDE DERIVATIVES AND NON-NUCLEOSIDE DERIVATIVES | RIBOZYME PHARMACEUTICALS, INCORPORATED (US) | 2002-03-07 | — | — | WO | claimed |
| EP-1108724-A2 | Synthesis of methoxy nucleosides and enzymatic nucleic acid molecules | RIBOZYME PHARMACEUTICALS, INC. (US) | 2001-06-20 | — | — | EP | claimed |
| US-5962675-A | Chemical syntheses of 2'-O-methoxy purine nucleosides | RIBOZYME PHARMACEUTICALS, INC. (US) | 1999-10-05 | — | — | US | claimed |
| US-5767270-A | PROTECTING EXOCYCLIC AMINO GROUPS | ISIS PHARMACEUTICALS, INC. (US) | 1998-06-16 | — | — | US | claimed |
| CN-1147815-A | Adenosine derivatives | SANDOZ LTD (CH) | 1997-04-16 | — | — | CN | claimed |
| WO-1996041812-A1 | OLIGONUCLEOTIDE PHOSPHORYLATION METHOD AND PRODUCTS | ISIS INNOVATION LIMITED (GB) | 1996-12-27 | — | — | WO | claimed |